---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-047614"
form_type: "8-K"
ticker: "CURX"
cik: "0002025942"
company_name: "Curanex Pharmaceuticals Inc"
filed_at: "2026-10-19T21:15:25+00:00"
generated_at: "2026-10-19T21:16:07.460325+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Curanex faces two putative securities class actions over August 2025 IPO disclosures

## Summary
- Daymond Morales filed Action 1 on July 23, 2026 in New York Supreme Court (Index 159271/2026) against Curanex and underwriters Dominari, Pacific Century and Revere.
- Robert Lovett filed Action 2 on Sept. 14, 2026 (Index 655238/2026) against Curanex, its former CFO, directors, auditor and the same IPO underwriters.
- Both suits allege Sections 11 and 12(a)(2) violations over the August 2025 IPO offering documents, citing stock-price manipulation risks and underwriter due-diligence and AML deficiencies.
- Curanex says neither complaint asserts fraud against it, intends to defend vigorously; response deadlines are Nov. 15, 2026 for Morales and Dec. 11, 2026 for Lovett.

## SEC filing metadata
- accession: 0001493152-26-047614
- form_type: 8-K
- ticker: CURX
- cik: 0002025942
- company_name: Curanex Pharmaceuticals Inc
- filed_at: 2026-10-19T21:15:25+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2025942/000149315226047614/0001493152-26-047614-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2025942/000149315226047614/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-047614
- JSON: https://secwatch.observer/filing/0001493152-26-047614.json
- Plain text: https://secwatch.observer/filing/0001493152-26-047614.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.